tirzepatide fat oxidation did not impact metabolic adaptation in people with obesity, but increased Tirzepatide levocarnitine: complete guide to

Mean weight reductions were: 15 mg dose: 20.9 percent 10 mg dose: 19.5 percent 5 mg dose: 15.0 percent Placebo: 3.1 percent At the highest dose, 57 percent of participants lost at least 20 percent of their body weight, and 36 percent lost at least 25 percent [2]

[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Yang J., Liu X., Fu Y., Song Y

It is important to rotate the injection site each week to prevent skin irritation or other issues at one site

If nausea is bothersome, discuss over-the-counter options with our team

They might adjust your dosage or explore alternative treatments

Obesity and metabolic disorders are also commonly linked to reproductive issues such as polycystic ovary syndrome (PCOS) 95 and erectile dysfunction (ED) 96